FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
Barclays raised its price target on Acceleron Pharma (NASDAQ: XLRN) to $50.00 (from $42.00) while maintaining a Overweight rating. Analyst... More